missing translation for 'onlineSavingsMsg'
Learn More
Learn More
TRANCE/TNFSF11/RANK L Antibody (12A668) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody has been used in 11 publications
Brand: Bio-Techne NB100-56593SS
This item is not returnable.
View return policy
Description
TRANCE/TNFSF11/RANK L Monoclonal specifically detects TRANCE/TNFSF11/RANK L in Human, Mouse, Rat samples. It is validated for Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, CyTOF-ready.Specifications
TRANCE/TNFSF11/RANK L | |
Monoclonal | |
1.0 mg/mL | |
Western Blot 1-2 ug/ml, Chromatin Immunoprecipitation 1:10-1:500. Use reported in scientific literature (PMID 25859979), Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin 1 - 5 ug/ml, Chromatin Immunoprecipitation (ChIP) 1:10-1:500, CyTOF-ready | |
CD254, CD254 antigen, OPGLOPTB2, Osteoclast differentiation factor, Osteoprotegerin ligand, RANKLreceptor activator of nuclear factor kappa B ligand, Receptor activator of nuclear factor kappa-B ligand, sOdf, TNF-related activation-induced cytokine, TRANCEODFhRANKL2, tumor necrosis factor (ligand) superfamily, member 11, tumor necrosis factor ligand superfamily member 11 | |
Mouse | |
35 kDa | |
0.025 mg | |
Cancer | |
8600 | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG1 κ |
Western Blot, ChIP Assay, Flow Cytometry, Immunohistochemistry, Immunocytochemistry | |
12A668 | |
Unconjugated | |
O14788 | |
TNFSF11 | |
A bacterially expressed fusion protein containing amino acid residues 1-317 of mouse TRANCE was used as immunogen (NP_003692). | |
Protein G purified | |
RUO | |
Primary | |
Human, Mouse, Rat | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction